The VEGF inhibitor vatalanib regulates AD pathology in 5xFAD mice

Overview of attention for article published in Molecular Brain, September 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)

Mentioned by

news: 1 news outlet

twitter: 1 tweeter

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 6 Mendeley

Summary News Twitter Dimensions citations

So far, Dimensions has found 5 publications that cite this research output.

5

The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.

Vascular endothelial‐cadherin as a marker of endothelial injury in preclinical Alzheimer disease

Article in Annals of Clinical and Translational Neurology (November 2022)

Combinatorial delivery of CPI444 and vatalanib loaded on PEGylated graphene oxide as an effective nanoformulation to target glioblastoma multiforme: In vitro evaluation

Article in Frontiers in Oncology (August 2022)

The Periodontal Pathogen Fusobacterium nucleatum Exacerbates Alzheimer’s Pathogenesis via Specific Pathways

Article in Frontiers in Aging Neuroscience (June 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.